.@GileadSciences paid its former CEO $180 mil, while making billions in profit from lifesaving HIV drugs that are unaffordable for people who need them. The kicker: those drugs were developed using tens of millions of TAXPAYER dollars.

.@GileadSciences paid its former CEO $180 mil, while making billions in profit from lifesaving HIV drugs that are unaffordable for people who need them. The kicker: those drugs were developed using tens of millions of TAXPAYER dollars.

And someone needed to call 'em out. 🗣️ pic.twitter.com/r3rBBrFAVO

— Rep. Katie Hill (@RepKatieHill) May 16, 2019